Tocilizumab Induced Acquired Factor XIII Deficiency in Patients with Rheumatoid Arthritis

Factor XIII is one of the twelve coagulation factors and also known as a fibrin-stabilizing factor. In 2012, we encountered a male RA patient with hemorrhagic factor XIII deficiency who had been treated with tocilizumab for two years. There are few reports regarding the relationship between tocilizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokuda, Sho, Murata, Yosuke, Sawada, Naoya, Matoba, Kenichiro, Yamada, Akihiro, Onishi, Makoto, Okuda, Yasuaki, Jouyama, Kazuo, Sugiyama, Eiji, Takasugi, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731329/
https://www.ncbi.nlm.nih.gov/pubmed/23936360
http://dx.doi.org/10.1371/journal.pone.0069944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731329/
https://www.ncbi.nlm.nih.gov/pubmed/23936360
http://dx.doi.org/10.1371/journal.pone.0069944

Ejemplares similares